ArticleCurrent research in pharmacology and drug discovery2021

Reversal of TGF-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma by sorafenib, a VEGFR-2 and Raf kinase inhibitor.

Siddharth J Modi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.